Do you routinely integrate telomere length testing into the evaluation of patients with ILD?

"Routine" would be a stretch, but I have dramatically increased my utilization of telomere length testing with the publication of recent studies, including this one. I do not check telomere lengths in patients when I don't think it will impact my management, but there is uncertainty surrounding best...

Not routinely unless the patient or caregiver have evidence of premature graying, liver cirrhosis, blood or marrow abnormalities. I would also consider it in rapidly deteriorating ILD or IPF. How this would affect my overall management is less algorithmic but more individually based.

I will apologize in advance, I don't have sources to my answer below. I loved this paper when it came through late last year! That said, I tend to do the same as detailed by Dr. Taskar. I wonder about several things in my day-to-day practice:

1. Is the premature greying piece really the best thing to ...